Abacus Life Earnings Call Highlights Surging Growth

Abacus Life, Inc. ((ABX)) has held its Q4 earnings call. Read on for the main highlights of the call.

Abacus Life, Inc. struck an upbeat tone on its latest earnings call, underscoring powerful growth in revenue, profitability and assets under management alongside rapid traction for its proprietary mortality data platform. Management balanced that optimism with candid discussion of leverage, GAAP versus non-GAAP gaps and volatile quarterly spreads, but framed these as manageable against strong momentum.

Consistent Outperformance and High-Return Track Record

Abacus highlighted eleven consecutive quarters of beating consensus expectations, pointing to a multi-quarter run in which adjusted net income and adjusted EBITDA have roughly tripled. The company also emphasized margin expansion from about 48% to 60% and noted that both return on equity and return on invested capital have consistently been at or above 20%.

Surging Top-Line Growth Across the Franchise

Management reported that full-year 2025 revenue jumped 110% to $235.2 million, up from $111.9 million in 2024, underscoring broad-based momentum in the core business. Fourth-quarter revenue was similarly strong, rising 116% year over year to $71.9 million compared with $33.2 million in the prior-year period.

Rapid Expansion in Adjusted Profitability

Adjusted net income for 2025 rose 84% to $85.7 million from $46.5 million, while adjusted EBITDA climbed 115% to $132.6 million from $61.6 million. The company maintained a robust adjusted EBITDA margin of roughly 56% for the year, slightly above the prior year’s 55% and reinforcing the scalability of its model.

Record Origination and Capital Deployment Levels

Abacus posted record capital deployment in the fourth quarter of 2025 at $230.7 million, which management described as the strongest quarter in the company’s history. For the full year, capital deployment reached $580.8 million, an 82% increase versus the prior year and a key driver of future cash flows.

Growing Fee-Paying AUM and Management Fees

Fee-paying assets under management reached approximately $3.3 billion, with asset management activities generating nearly $33.8 million in management fees in 2025. Longevity funds attracted around $630 million of inflows, and the company is targeting more than $5 billion of fee-paying AUM by the end of 2026 as it scales its fund platform.

Scaling Proprietary Data and Technology Platforms

The Abacus Intel and mVerify platforms delivered roughly fourfold growth, now tracking nearly 3 million lives, which represents more than 300% year-over-year expansion. Management cited approximately 97% coverage with less than 1% error and mortality event detection in about 48 hours, positioning the offering for SaaS-like recurring revenue and institutional use cases.

Healthy Origination Economics and Realized Gains

Average realized gains came in at 27% in the fourth quarter and 32% for the full year, comfortably above the company’s 20% target. Abacus also reported portfolio annualized turnover of 2.6 times, exceeding its 1.5 to 2.0 times goal and signaling a disciplined but active approach to originating and monetizing policies.

Capital Allocation and Shareholder-Friendly Actions

The board authorized an additional $20 million share repurchase program, layered on top of an earlier $10 million authorization, while the company also returned capital via a dividend funded from recurring net income. Abacus completed its inaugural securitization and is aiming for larger, repeat securitizations, which could further optimize its balance sheet and funding costs.

Leverage and Liquidity Remain Key Watchpoints

As of year-end 2025, Abacus held $38.1 million of cash and cash equivalents against $405.8 million of long-term debt, leaving a relatively thin near-term liquidity buffer. Management acknowledged this high leverage profile as a risk factor that investors should monitor closely, even as securitizations and recurring fees help support the capital structure.

Valuation Disconnect and Market Perception Issues

Executives addressed what they see as a significant gap between the company’s fundamentals and its public market valuation following last year’s stock sell-off. They also noted that founders and insiders hold roughly 58% to 60% of the shares, which may constrain free float and trading liquidity, potentially contributing to the perception discount.

GAAP Versus Adjusted Metrics and Earnings Quality

The company relies heavily on non-GAAP measures, with the quarter’s GAAP net income at $7.2 million compared with materially higher adjusted net income and EBITDA. Management encouraged investors to reconcile the adjustments, which include non-cash items and fair value marks, underscoring the complexity of analyzing reported profitability.

Quarterly Margin Compression and Spread Volatility

Abacus reported that its quarterly realized gain metric declined compared with the third quarter, with a trade spread KPI moving from about 37% in Q3 to roughly 26% in Q4. Leadership framed this as normal quarter-to-quarter volatility in origination monetization and spreads rather than a structural deterioration in unit economics.

Rising SG&A and Integration-Related Spending

Total operating expenses excluding unrealized gains were $41.1 million in 2025, actually down year over year largely due to lower stock-based compensation. However, the company saw higher SG&A driven by acquisitions completed in 2024 and mid-2025, as well as stepped-up marketing spend aimed at building its growth profile and brand.

Selectivity and Conversion Limits in Origination

The origination close rate on qualified policies was about 12%, which management presented as evidence of disciplined underwriting and margin protection. At the same time, this low conversion rate highlights limits in turning a large pipeline of reviewed policies into completed transactions, potentially constraining growth if origination funnels are not expanded.

Forward-Looking Guidance and Long-Term Ambitions

Abacus initiated 2026 guidance for adjusted net income between $96 million and $104 million, implying potential growth of up to roughly 22% versus 2025, and it is targeting more than $5 billion in fee-paying AUM with over $3 million in technology revenue. Longer term, management outlined aggressive milestones including sharp EBITDA and AUM expansion through 2028 and 2030, with a higher mix of recurring revenue as asset management and data platforms scale.

Abacus Life’s earnings call painted a picture of a company growing quickly and leaning into recurring, fee-based and data-driven revenue streams while returning capital and pushing securitizations to fund expansion. Investors will need to weigh the strong operating momentum and high returns against leverage, valuation friction and earnings complexity, but management’s confidence and clear strategy suggest the growth story is far from over.